function sa(url,headline_text,source,media_type,cluster,tagline,document_url,harvest_time,access_status,access_registration) 
{
   this.url = url;
   this.headline_text = headline_text;
   this.source = source;
   this.media_type = media_type;
   this.cluster = cluster;
   this.tagline = tagline;
   this.document_url = document_url;
   this.harvest_time = harvest_time;
   this.access_status = access_status;
   this.access_registration = access_registration;
}
article = new Array(
  new sa("http://click.pulse360.com/cgi-bin/clickthrough.cgi?db=context&position=7001&tid=bhnibmnlbnnobknpbgnjzb&eid=1&id=92366688&creative=273855&query=general%20network%3A(general)&clickfactor_impression=1&clickid=87870965&tz=US&UNQ=00000126578490349724111000000106056049&value=JXDT73MZ7B3CU&origvalue=JXDT73MZ7B3CU&cgroup=&search=liver%25disease","Your Recession Escape Plan Is Here","Sponsored Link","text","moreover..."," ","http://click.pulse360.com/cgi-bin/clickthrough.cgi?db=context&position=7001&tid=bhnibmnlbnnobknpbgnjzb&eid=1&id=92366688&creative=273855&query=general%20network%3A(general)&clickfactor_impression=1&clickid=87870965&tz=US&UNQ=00000126578490349724111000000106056049&value=JXDT73MZ7B3CU&origvalue=JXDT73MZ7B3CU&cgroup=&search=liver%25disease","9 Feb 2010 15:40:00"," "," "),
  new sa("http://c.moreover.com/click/here.pl?j2536399369","Billings reacts to 3rd \"drunkest\" stigma","KTVQ.com","text","moreover...","","http://www.ktvq.com","9 Feb 2010 15:40:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2536389085","Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025","Therapeutics Daily","text","moreover...","","http://www.therapeuticsdaily.com","9 Feb 2010 15:34:00","prem","http://www.therapeuticsdaily.com/register/index.cf"),
  new sa("http://c.moreover.com/click/here.pl?j2536293067","Coventry News: Heavy drinkers 'don't realise the health risks'","Coventry Telegraph","text","moreover...","","http://coventrytelegraph.net","9 Feb 2010 15:05:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2536257311","Excelsior Medical?s New Catheter Lock Solution Approved by Health Canada","PR inside","text","moreover...","","http://pr-inside.com","9 Feb 2010 14:53:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2536252748","Novartis International AG (CH) - Novartis gains exclusive rights to Debio 025, an antiviral agent in Phase IIb development as potential first-in-class hepatitis C therapy","Therapeutics Daily","text","moreover...","","http://www.therapeuticsdaily.com","9 Feb 2010 14:52:00","prem","http://www.therapeuticsdaily.com/register/index.cf"),
  new sa("http://c.moreover.com/click/here.pl?j2536157090","Novartis (NVS) Gains Rights to Develop and Distribute Debio 025; Currently in Phase IIb","Street Insider","text","moreover...","","http://streetinsider.com","9 Feb 2010 14:20:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2536079620","Excelsior Medicals New Catheter Lock Solution Approved by Health Canada","Business Wire UK","text","moreover...","","http://www.businesswire.com","9 Feb 2010 13:41:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2536057013","Excelsior Medical's New Catheter Lock Solution Approved by Health Canada","Yahoo! Canada","text","moreover...","","http://ca.us.biz.yahoo.com","9 Feb 2010 13:32:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2536044157","Excelsior Medicals New Catheter Lock Solution Approved by Health Canada","Business Wire","text","moreover...","","http://www.businesswire.com","9 Feb 2010 13:27:00","",""),
  new sa("http://c.moreover.com/click/here.pl?j2536031350","Excelsior Medical's New Catheter Lock Solution Approved by Health Canada","Business Wire via Yahoo!","text","moreover...","","http://biz.yahoo.com","9 Feb 2010 13:22:00","","")
);
 